Literature DB >> 8287355

Increased blood flow in human brain tumor after administration of angiotensin II: demonstration by PET.

N Tomura1, T Kato, I Kanno, F Shishido, A Inugami, K Uemura, S Higano, H Fujita, K Mineura, M Kowada.   

Abstract

To evaluate the changes of regional cerebral blood flow (CBF) in artificial hypertensive state, we investigated vascular responses to changes of arterial carbon dioxide tension (PCO2) and blood pressure by means of positron emission tomography (PET). The subjects were eight brain tumors which were histologically proven. We calculated CBF changes in hypercapnic and hypocapnic state, and then using those results, CBF changes in hypertensive state were corrected. Every patient represented a selective increase of tumor blood flow in hypertensive state induced by angiotensin II, demonstrating a loss of autoregulation in tumor. Our results suggested the possibility of enhancement of chemotherapy for brain tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8287355     DOI: 10.1016/0895-6111(93)90060-z

Source DB:  PubMed          Journal:  Comput Med Imaging Graph        ISSN: 0895-6111            Impact factor:   4.790


  5 in total

Review 1.  Angiotensin and cerebral blood flow.

Authors:  J M Saavedra; Y Nishimura
Journal:  Cell Mol Neurobiol       Date:  1999-10       Impact factor: 5.046

2.  Reproducibility of tumor blood flow quantification with 15O-water PET.

Authors:  Martin A Lodge; Heather A Jacene; Roberto Pili; Richard L Wahl
Journal:  J Nucl Med       Date:  2008-10       Impact factor: 10.057

3.  Hemispheric differences in cerebral autoregulation in children with moderate and severe traumatic brain injury.

Authors:  Monica S Vavilala; Nuj Tontisirin; Yuthana Udomphorn; William Armstead; Jerry J Zimmerman; Randall Chesnut; Arthur M Lam
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

4.  Alterations in Gene Expression of Components of the Renin-Angiotensin System and Its Related Enzymes in Lung Cancer.

Authors:  Benjamin Goldstein; Malav Trivedi; Robert C Speth
Journal:  Lung Cancer Int       Date:  2017-07-16

Review 5.  Angiotensin II: a new therapeutic option for vasodilatory shock.

Authors:  Rachel L Bussard; Laurence W Busse
Journal:  Ther Clin Risk Manag       Date:  2018-07-26       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.